S&P Global Investing Cash Flow increased by 161.7% to $291.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 468.4%, from -$79.00M to $291.00M.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q1 '24 | Q2 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$9.00M | -$9.00M | -$78.00M | $2.90B | $844.00M | -$253.00M | $909.00M | -$20.00M | -$299.00M | -$79.00M | -$52.00M | -$101.00M | -$472.00M | $291.00M |
| QoQ Change | — | +0.0% | -766.7% | >999% | -70.9% | -130.0% | +459.3% | -102.2% | <-999% | +73.6% | +34.2% | -94.2% | -367.3% | +161.7% |
| YoY Change | — | — | — | — | >999% | -108.7% | +7.7% | +92.1% | -132.9% | -295.0% | +82.6% | — | — | +468.4% |